Peer-influenced content. Sources you trust. No registration required. This is HCN.

Roswell ParkRoswell Park Researchers Present New Approach to Understanding Challenging CAR T-Cell Toxicities

Payal Goala, MS, BS, a pre-doctoral fellow at Roswell Park Comprehensive Cancer Center, presented research findings at the 64th annual meeting of the American Society of Hematology (ASH), held December 10–13 in New Orleans, Louisiana. Her work may help address neutropenia and cytokine release syndrome, two serious side effects of chimeric antigen receptor (CAR) T-cell therapy. The research is being hailed as a “significant advancement” in the knowledge of these toxicities and is expected to help patients receiving CAR-T therapy live better lives.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form